Trexquant Investment’s Dyne Therapeutics DYN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.45M | Buy |
362,310
+27,867
| +8% | +$265K | 0.04% | 675 |
|
|
2025
Q1 | $3.5M | Buy |
334,443
+209,065
| +167% | +$2.19M | 0.04% | 653 |
|
|
2024
Q4 | $2.95M | Buy |
125,378
+61,288
| +96% | +$1.44M | 0.03% | 713 |
|
|
2024
Q3 | $2.3M | Sell |
64,090
-17,872
| -22% | -$642K | 0.03% | 759 |
|
|
2024
Q2 | $2.89M | Buy |
81,962
+42,983
| +110% | +$1.52M | 0.04% | 595 |
|
|
2024
Q1 | $1.11M | Buy |
38,979
+16,157
| +71% | +$459K | 0.02% | 881 |
|
|
2023
Q4 | $304K | Buy |
+22,822
| New | +$304K | 0.01% | 1246 |
|
|
2023
Q3 | – | Sell |
-27,380
| Closed | -$308K | – | 1544 |
|
|
2023
Q2 | $308K | Sell |
27,380
-15,089
| -36% | -$170K | 0.01% | 1187 |
|
|
2023
Q1 | $489K | Buy |
42,469
+14,378
| +51% | +$166K | 0.01% | 1009 |
|
|
2022
Q4 | $326K | Sell |
28,091
-8,476
| -23% | -$98.2K | 0.01% | 1073 |
|
|
2022
Q3 | $464K | Buy |
+36,567
| New | +$464K | 0.02% | 843 |
|
|
2022
Q1 | – | Sell |
-20,232
| Closed | -$241K | – | 1441 |
|
|
2021
Q4 | $241K | Sell |
20,232
-7,622
| -27% | -$90.8K | 0.01% | 1039 |
|
|
2021
Q3 | $452K | Buy |
+27,854
| New | +$452K | 0.04% | 577 |
|